Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?

@article{Candiotti2010ReviewOT,
  title={Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?},
  author={K. Candiotti and M. Gitlin},
  journal={Current Medical Research and Opinion},
  year={2010},
  volume={26},
  pages={1677 - 1684}
}
  • K. Candiotti, M. Gitlin
  • Published 2010
  • Medicine
  • Current Medical Research and Opinion
    • Abstract Objective: Opioids are among the most effective and potent analgesics currently available. Their utility in the management of pain associated with cancer, acute injury, or surgery is well recognized. However, extending the application of opioids to the management of chronic non-cancer pain has met with considerable resistance. This resistance is due in part to concerns related to gastrointestinal and central nervous system-related adverse events as well as issues pertaining to… CONTINUE READING
    View on Taylor & Francis
    ncbi.nlm.nih.gov
    Top 3 of 50 Citations
    Recent advances in opioid prescription for chronic non-cancer pain
    S. Snidvongs, V. MehtaPostgraduate Medical Journal2011
    12
    Effectiveness of long-term opioid therapy for chronic non-cancer pain.
    L. Manchikanti, R. Vallejo, … P. ChristoPain physician2011
    129
    Opioid-Induced Constipation: Challenges and Therapeutic Opportunities
    M. CamilleriThe American Journal of Gastroenterology2011
    199
    50 Citations
    Citation Type

    Citation Type

    Recent advances in opioid prescription for chronic non-cancer pain
    • 12
    Effectiveness of long-term opioid therapy for chronic non-cancer pain.
    • 129
    • PDF
    Opioid-Induced Constipation: Challenges and Therapeutic Opportunities
    • 199
    Opioid-induced constipation
    • 9
    Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective.
    • 467
    Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    • 180
    • PDF
    Economic study on the impact of side effects in patients taking oxycodone controlled-release for noncancer pain.
    • 21
    • PDF
    Budget impact analysis of tapentadol extended release for the treatment of moderate to severe chronic noncancer pain.
    • 13
    American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
    • 153
    • PDF
    Comparative pharmacology and toxicology of tramadol and tapentadol
    • 20

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 94 REFERENCES
    Opioid complications and side effects.
    • 1,072
    • PDF
    Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review.
    • 374
    Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects
    • 746
    • PDF
    The use of opioids in the treatment of osteoarthritis: When, why, and how?
    • 26
    Opioid therapy for chronic noncancer pain: practice guidelines for initiation and maintenance of therapy.
    • 81
    The role of opioids in managing chronic non-cancer pain.
    • 32
    • PDF
    Opioid induced hyperalgesia: clinical implications for the pain practitioner.
    • 197
    • PDF
    Risk-Benefit Assessment of Opioids in Chronic Noncancer Pain
    • 89
    Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    • 40
    Opioids for managing chronic non-malignant pain: safe and effective prescribing.
    • 28